Wegovy, also known as semaglutide 2.4 mg, is a prescription drug approved by the US Food and Drug Administration (FDA) for chronic weight control in individuals with obesity or overweight and at least one weight-related disorder.

Weight reduction with Wegovy can happen at different rates for different people. Wegovy has been shown in clinical trials to cause significant weight loss over a certain period. Individual responses to the medicine, however, may vary.

Individuals utilizing Wegovy obtained better weight loss in clinical studies than those who did not use the medicine. Clinical trials are often short, and the long-term effects and maintenance of weight loss with Wegovy over extended periods are still being investigated.

It is critical to remember that Wegovy should only be used under the supervision and advice of a healthcare expert. They can advise you on projected weight loss rates depending on your health profile and help you monitor for any potential adverse effects.

Total Compounding Pharmaceuticals is an excellent place to start if you want to start using treatment options for those who are obese. They intend to change the way patients receive medical care.

There are others. See circled below

Some of those drugs can work temporarily but most people often gain weight back when they resort to their old habits of overeating and inactive lifestyle.There are no quick fix to prevent obesity.Physical exercises and cutting down on food portion has been proven to be the only methods.The key is being consistent and disciplined to get results.Sadly,Black people are the fattest race in the USA and UK primarily because of the sedentary lifestyle that they live.Nigerians abroad top the chart.